The bacA gene, the overexpression of which results in bacitracin resistance, was inactivated and shown to be non-essential for growth of Escherichia coli. It was proposed earlier that the bacA gene product may confer resistance to the antibiotic by phosphorylation of undecaprenol (Cain, B. D., Norton, P. J., Eubanks, W., Nick, H. S., and Allen, C. M. (1983) J. Bacteriol. 175, 3784 -3789). In the present work, this extremely hydrophobic membrane protein was overproduced and purified to near homogeneity. The analysis of its catalytic properties clearly demonstrated that the purified BacA protein exhibited undecaprenyl pyrophosphate phosphatase activity but not undecaprenol phosphokinase activity. This finding was perfectly consistent with the mechanism of action of bacitracin that consists in the sequestration of undecaprenyl pyrophosphate, the BacA enzyme substrate. The level of undecaprenyl pyrophosphate phosphatase was increased by 280-fold in cells carrying bacA on a multicopy expression plasmid. It was decreased by ϳ75% but was not completely abolished in a bacA disruption mutant, suggesting that BacA is the main E. coli undecaprenyl pyrophosphate phosphatase but that other protein(s) exhibiting such an activity should exist to account for the residual activity and viability of the mutant strain. This is the first gene encoding undecaprenyl pyrophosphate phosphatase identified to date. Considering its newly identified function, we propose to rename the bacA gene uppP.
The bacA gene, the overexpression of which results in bacitracin resistance, was inactivated and shown to be non-essential for growth of Escherichia coli. It was proposed earlier that the bacA gene product may confer resistance to the antibiotic by phosphorylation of undecaprenol (Cain, B. D., Norton, P. J., Eubanks, W., Nick, H. S., and Allen, C. M. (1983) J. Bacteriol. 175, 3784 -3789). In the present work, this extremely hydrophobic membrane protein was overproduced and purified to near homogeneity. The analysis of its catalytic properties clearly demonstrated that the purified BacA protein exhibited undecaprenyl pyrophosphate phosphatase activity but not undecaprenol phosphokinase activity. This finding was perfectly consistent with the mechanism of action of bacitracin that consists in the sequestration of undecaprenyl pyrophosphate, the BacA enzyme substrate. The level of undecaprenyl pyrophosphate phosphatase was increased by 280-fold in cells carrying bacA on a multicopy expression plasmid. It was decreased by ϳ75% but was not completely abolished in a bacA disruption mutant, suggesting that BacA is the main E. coli undecaprenyl pyrophosphate phosphatase but that other protein(s) exhibiting such an activity should exist to account for the residual activity and viability of the mutant strain. This is the first gene encoding undecaprenyl pyrophosphate phosphatase identified to date. Considering its newly identified function, we propose to rename the bacA gene uppP.
Undecaprenyl phosphate (C 55 -P) 1 is a key lipid intermediate involved in the synthesis of various bacterial cell wall polymers such as peptidoglycan, lipopolysaccharides, and teichoic acids (1) (2) (3) (4) (5) . This carrier lipid enables the transport of hydrophilic precursors through the hydrophobic environment of the membrane to the externally located sites of polymerization. Because a single lipid participates in the synthesis of various wall polymers, C 55 -P has been considered previously to be a potential site of control over the synthesis of these polymers that prevents an imbalance in the formation of the cell envelope as a whole (6) . However, our knowledge of C 55 -P metabolism remains very limited and based on fragmentary data obtained from various bacterial species (Scheme 1). The precursor for C 55 -P, undecaprenyl pyrophosphate (C 55 -PP), is synthesized by addition of isoprene units onto farnesyl pyrophosphate (Scheme 1, step 1). This reaction is catalyzed by a cis-prenyl pyrophosphate synthase that has been characterized in detail both biochemically and structurally (7) (8) (9) (10) (11) . The dephosphorylation of C 55 -PP (Scheme 1, step 2) is required before the lipid carrier becomes available for use in the various biosynthetic pathways, and this reaction must also occur at the end of each cycle of polymerization reaction (e.g. of peptidoglycan) where the lipid carrier is released in the pyrophosphate form. This reaction of dephosphorylation, which is the site of action of bacitracin, is catalyzed by a membrane-bound phosphatase (12) . The intriguing presence of free undecaprenol (C 55 -OH) in bacterial membranes has been reported (13) . It could represent a reserve pool for the regulation of the C 55 -P pool, a hypothesis that seems to be corroborated by the detection of two membrane-associated enzyme activities, an undecaprenol phosphokinase and an undecaprenyl phosphate phosphatase, catalyzing the interconversion of C 55 -OH and C 55 -P (Scheme 1, steps 3 and 4). Few data on genes and enzymes involved in steps 2, 3, and 4 are available (14 -17) . Recently, as discussed below, the Escherichia coli gene for the undecaprenol phosphokinase was tentatively identified as bacA (18) .
Bacitracin is a mixture of related cyclic polypeptide antibiotics produced by some strains of Bacillus licheniformis and Bacillus subtilis. This potent antibiotic is used clinically for treatments of surface tissue infections in combination with other antimicrobial drugs. Its primary mode of action is the inhibition of bacterial cell wall synthesis through sequestration of the essential carrier lipid C 55 -PP, resulting in the loss of cell integrity and lysis (19 -22) . An active ATP-dependent ABCtype efflux system comprised of three BcrA, -B, and -C proteins is responsible for the resistance of B. licheniformis to the antibiotic (23, 24) . However, little is known on the mechanisms developed by sensitive bacteria to resist bacitracin. In E. coli and some other Gram-negative bacteria, different mutations that block the synthesis of exopolysaccharides have been shown to also lead to bacitracin resistance (25, 26) . Presumably the synthesis of these non-essential polymers also requires the same C 55 -P transporter, and these mutations therefore indirectly provide an increased supply of this transporter for the * This work was supported by grants from the European Community (FP6, LSHM-CT-2003-503335, "COBRA" project) and from the CNRS (UMR 8619). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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§ To whom correspondence should be addressed. synthesis of the essential cell wall component, peptidoglycan. Two E. coli genes whose overexpression in plasmids confers bacitracin resistance have been recently identified. The first one, bcrC, encodes a homologue of the BcrC subunit of the bacitracin transport permease from B. licheniformis, but the mechanism by which increased expression of this gene product modulates antibiotic resistance is yet unknown (27) . Overexpression of the second gene, bacA, has been shown to confer a moderate 4-fold increase of undecaprenol phosphokinase activity in membranes, and it was thus hypothesized that this gene codes for the latter enzyme activity (18) . Homologues of bacA have since been identified in Staphylococcus aureus and Streptococcus pneumoniae (28) . Although bacA appears to be nonessential for in vitro growth of these two pathogenic organisms, its inactivation results in increased bacitracin susceptibility and reduced virulence with the maximal effects being observed in S. pneumoniae (28) . In fact, no demonstration that the E. coli bacA gene is also non-essential for growth has been presented to date. Attempts to disrupt its homologue in the B. subtilis chromosome have been reported recently to be unsuccessful, suggesting that bacA is essential in the latter species (29) . Furthermore, with only one exception (18) , none of the different previous reports on bacA include any data on the biochemical and functional characterization of the gene product. As mentioned by Cain and co-workers (18) , although suggestive, the evidence provided in their report was not sufficient to conclude that the bacA gene encodes undecaprenol phosphokinase. It was thus necessary to reinvestigate the function of BacA by performing the complete set of experiments in a single bacterial species. This report describes such experiments performed in E. coli. The bacA gene was proved to be non-essential for growth, and the effects of its expression on bacitracin resistance were described. The BacA membrane protein was overproduced, extracted from membranes with a detergent, and purified to near homogeneity in the histidine-tagged form. Appropriate enzymatic assays showed that BacA does not exhibit undecaprenol phosphokinase activity but does exhibit undecaprenyl pyrophosphate phosphatase activity, a finding that is perfectly consistent with the associated bacitracin resistance phenotype.
EXPERIMENTAL PROCEDURES

Bacterial Strains, Plasmids, and Growth Conditions
The E. coli strains DH5␣ (supE44 ⌬lacU169 hsdR17 recA1 endA1 gyrA96 thi-1 relA1 ⌽80 dlacZ ⌬M15) (Invitrogen) and JM83 (ara ⌬[lacproAB] rpsL thi 80 dlacZ ⌬M15) (30) were used as hosts for plasmids. The C43(DE3) strain used for the overproduction of the BacA protein was obtained from Avidis-France. The plasmid vector pTrc99A was obtained from Amersham Biosciences, and the construction of pTrcHis30 has been described previously (31) . The construction of plasmid pET2130, a pET21d (Novagen) derivative for expression of proteins with an N-terminal His 6 tag, is detailed below. The BW25113 strain and the pKD3, pKD4, pKD46, and pCP20 plasmids used for gene disruption experiments (32) were kindly provided by B. Wanner via the E. coli Genetic Stock Center (Yale University, New Haven, CT). The construction of the BW25113 ⌬bacA::Cm R strain is described below. 2YT (33) was used as culture medium, and growth was monitored at 600 nm with a Shimadzu UV-1601 spectrophotometer. For strains carrying drug resistance genes, ampicillin, kanamycin, and chloramphenicol were used at the concentrations of 100, 35, and 25 g⅐ml Ϫ1 , respectively.
General DNA Techniques and E. coli Cell Transformation
PCR amplification of genes from the E. coli chromosome was performed in a Thermocycler 60 apparatus (Bio-med) using the polymerase Expand-Fidelity from Roche Applied Science. The DNA fragments were purified using the Wizard PCR Preps DNA purification kit (Promega). Small and large scale plasmid isolations were carried out by the alkaline lysis method, and standard procedures for endonuclease digestions, ligation, and agarose electrophoresis were used (34) . E. coli cells were made competent for transformation with plasmid DNA by the method of Dagert and Ehrlich (35).
Construction of Expression Plasmids
A first plasmid suitable for overproduction of wild-type BacA was constructed as follows. PCR primers (Table I) were designed to incorporate a BspHI site 5Ј to the initiation codon of bacA (primer Bac1) and a PstI site 3Ј to the gene after the stop codon (primer Bac2). The DNA fragment amplified from the E. coli chromosome was treated with BspHI and PstI and ligated between the compatible NcoI and PstI sites of vector pTrc99A. The resulting plasmid, pTrcBac1, allowed expression of the wild-type bacA gene under the control of the strong isopropyl-␤-D-thiogalactopyranoside (IPTG)-inducible trc promoter. For expression of BacA in an N-terminal His 6 -tagged form, the gene was amplified with primers Bac2 and Bac3 (Table I) , and the resulting fragment was cut with BamHI and PstI and inserted between the same sites of vector pTrcHis30, generating plasmid pTrcBac30.
A plasmid allowing expression of the uppS gene from E. coli in the His 6 -tagged form under control of the T7 promoter was constructed as follows. First a vector, pET2130, was constructed that was derived from pET21d (Novagen) by removal (filling in) of its unique BglII site and replacement of the NcoI-HindIII polylinker by that from the pQE30 vector (Qiagen) as described previously for the construction of pTrcHis30 (31) . Primers Upp1 and Upp2 (Table I) were designed to incorporate a BamHI site 5Ј to the initiation codon of the uppS gene and a HindIII site 3Ј to the stop codon. The amplified fragment was treated with BamHI and HindIII and cloned between the same sites of vector pET2130, generating plasmid pETUppS. DNA sequencing was performed in all cases to confirm that the sequence of the cloned fragments was correct.
Construction of a Null bacA Mutant
The E. coli mutant strain BW25113 ⌬bacA::Cm R carrying a complete deletion of the bacA gene, which had been replaced by a chloramphenicol resistance gene, was created by following the method of Datsenko and Wanner (32) . The Inact1 and Inact2 oligonucleotides (Table I) were used for PCR amplification of the antibiotic resistance gene from pKD3 flanked by sequences designed for specific disruption of the bacA gene. The PCR product was transformed by electroporation into BW25113(pKD46) cells that express phage Red recombinase (32) . Chloramphenicol-resistant clones were isolated, and the disruption of the bacA gene in the chromosome was verified by PCR using the Bac1 and Bac2 primers.
Preparation of Crude Extracts and Purification of the
BacA Protein E. coli cells carrying plasmids described in this work were grown at 37°C in 2YT-ampicillin medium (1-liter cultures). When the optical density of the culture reached 0.15, IPTG was added at a final concentration of 1 mM, and growth was continued for 16 h. Cells were harvested and washed with 40 ml of cold 20 mM potassium phosphate buffer, pH 7.2, containing 1 mM MgCl 2 and 2 mM ␤-mercaptoethanol (buffer A). The cell pellet was suspended in 12 ml of the same buffer, SCHEME 1. Metabolism of undecaprenyl phosphate. PBPs, penicillin-binding proteins. and cells were disrupted by sonication in the cold (Bioblock Vibracell sonicator, model 72412). The resulting suspension was centrifuged at 4°C for 30 min at 200,000 ϫ g. The pellet consisting of membranes and associated proteins (420 mg of proteins) was washed twice with buffer A and subjected to solubilization by detergent as follows.
Membranes (2 g, wet weight) containing the overexpressed BacA protein were resuspended in 6 ml of buffer A supplemented with 150 mM NaCl and 20% glycerol. n-Dodecyl-␤-D-maltoside (DDM) (0.9%, w/v) was added, and the mixture was incubated for 2 h at 4°C with shaking. After centrifugation at 200,000 ϫ g for 30 min at 4°C, a first supernatant (DDM1) was recovered. The pellet of insoluble material was subjected again to three successive cycles of solubilization/centrifugation in the same conditions (except that DDM was used at 1%), yielding supernatants DDM2-DDM4, respectively.
The His 6 -tagged BacA protein was purified basically following the manufacturer's recommendations (Qiagen). Solubilized membrane proteins (DDM2 extract, 70 mg of proteins) were mixed and incubated for 2 h at 4°C with nickel-nitrilotriacetate (Ni 2ϩ -NTA)-agarose (20 mg of proteins/ml of resin) pre-equilibrated in buffer B (20 mM sodium phosphate, pH 7.2, 300 mM NaCl, 20% glycerol, 0.2% DDM, 1 mM MgCl 2 , 2 mM 2-mercaptoethanol). The resin was then washed with buffer B, and protein elution was performed with increasing concentrations of imidazole from 10 to 300 mM in buffer B. Elution of the protein was followed by SDS-PAGE and enzymatic assays. Pure protein-containing fractions were concentrated and dialyzed using a Vivaspin concentrator (Vivascience) against buffer B.
Synthesis of Radiolabeled Undecaprenyl Pyrophosphate
The E. coli uppS gene (8, 10) encoding undecaprenyl pyrophosphate synthase was cloned in the His 6 -tagged form in the expression vector pET2130 as described above. High level overexpression and purification of this protein on Ni 2ϩ -NTA-agarose yielded about 5 mg of pure enzyme/ liter of culture (data not shown). Synthesis of radiolabeled C 55 -PP was performed in a reaction mixture (20 l) containing 100 mM HEPES buffer, pH 7.5, 50 mM KCl, 0.5 mM MgCl 2 , 0.1% Triton X-100, 5 M farnesyl pyrophosphate, 50 M [ 14 C]isopentenyl pyrophosphate (2,035 Bq), and pure UppS enzyme (5 g). After 3 h of incubation at 25°C, the reaction was stopped by addition of 80 l of 0.4 M NaOH. The radiolabeled C 55 -PP synthesized was recovered by extraction with butanol and dried under vacuum. The identity of the product was confirmed by TLC analysis as described below.
Enzymatic Assays
Undecaprenol Phosphokinase Assay-The assay was performed in a reaction mixture (20 l) containing, in final concentrations, 100 mM Tris-HCl buffer, pH 7.5, 20 mM MgCl 2 , 0.6 mM C 55 -OH, 0.2% DDM, 0.1 mM [␥-32 P]ATP (4,500 Bq), and enzyme (150 g of protein). Undecaprenyl Pyrophosphate Phosphatase Assay-The assay was performed in a reaction mixture (20 l) containing 100 mM Tris-HCl buffer, pH 7.5, 10 mM MgCl 2 , 3.9 mM DDM, 5 M [
14 C]C 55 -PP (2,035 Bq), and enzyme.
Coupled Assay with MraY-The assay was performed in a reaction mixture (20 l) containing 100 mM Tris-HCl buffer, pH 7.5, 10 mM MgCl 2 , 3.9 mM DDM, 5 M [
14 C]C 55 -PP (2,035 Bq), 0.1 mM UDP-MurNAc-pentapeptide, 0.4 g of purified MraY, and BacA enzyme. In all cases, reaction mixtures were incubated for 30 min at 37°C, and reactions were stopped by heating at 100°C for 1 min. Substrates and reaction products were separated by TLC on precoated plates of silica gel 60 (Merck) using diisobutyl ketone/acetic acid/water (8:5:1, v/v/v) as a mobile phase. The radioactive spots were located and quantified with a radioactivity scanner (model Multi-Tracermaster LB285, BertholdFrance). Commercial unlabeled compounds were detected by ultraviolet absorption or reaction with iodine vapors. The R F values observed for ATP, MurNAc-(pentapeptide)-pyrophosphoryl-undecaprenol (lipid I), C 55 -PP, C 55 -P, and C 55 -OH were 0, 0.2, 0.36, 0.5, and 0.98, respectively. One unit of enzyme activity corresponds to one nanomole of product formed per minute.
Extraction of C 55 -P Reaction Product by Butanol
A standard C 55 -PP phosphatase assay was performed as described above except that C 55 -PP (1 nmol) was unlabeled. After the reaction had been stopped by addition of 20 l of 6 M pyridinium acetate, 40 l of 1-butanol were added, and the mixture was vortexed for 2 min and centrifuged at 10,000 ϫ g for 5 min. The organic phase was recovered, evaporated, taken up in 10 l of 2-propanol/methanol (1:1, v/v), and analyzed by mass spectrometry.
Protein Monitoring
SDS-PAGE analysis of proteins was performed as described by Laemmli and Favre (36). Protein concentrations were determined by using either the Bradford procedure (37) or the QuantiPro BCA assay kit (Sigma) with bovine serum albumin as the standard and/or by quantitative amino acid analysis with a Hitachi model L8800 analyzer (ScienceTec) after hydrolysis of samples in 6 M HCl for 24 h at 105°C.
Matrix-assisted Laser Desorption/Ionization Time-of-flight (MALDI-TOF) Mass Spectrometry Analysis
MALDI-TOF mass spectra were recorded in the linear mode with delayed extraction on a PerSeptive Voyager-DE STR instrument (Applied Biosystems) equipped with a 337 nm nitrogen laser.
BacA-The samples were prepared according to Grü ber et al. (38) . 0.5 l of BacA preparation was deposited on the plate and allowed to dry. Subsequently 0.5 l of matrix solution (10 mg/ml ␣-cyano-4-hydroxycinnamic acid in 50% (v/v) acetonitrile, 0.1% (v/v) trifluoroacetic acid) was applied to the dried sample and again allowed to dry. Spectra were recorded in the positive ion mode at an acceleration voltage of ϩ25 kV and an extraction delay time of 300 ns. Carbonic anhydrase was used as an external calibrant.
C 55 -P-1 l of matrix solution (10 mg/ml 2,5-dihydroxybenzoic acid in 20 mM diammonium citrate) was deposited on the plate followed by 0.5 l of sample dissolved in 2-propanol/methanol (1:1, v/v). After evaporation of the solvents, spectra were recorded in the negative ion mode at an acceleration voltage of Ϫ20 kV and an extraction delay time of 100 ns. A mixture of UDP-MurNAc, UDP-MurNAc-L-Ala, and UDP-MurNAc-L-Ala-D-Glu was used as an external calibrant.
Chemicals
DNA restriction and modification enzymes were obtained from New England Biolabs, and oligonucleotides were from MWG-Biotech. DNA purification kits were from Promega. C 55 -OH, C 55 -P, and C 55 -PP were provided by the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences. UDP-[U- 14 ) were from PerkinElmer Life Sciences. DDM was from Fluka, and Ni 2ϩ -NTA agarose was from Qiagen. UDP-MurNAc-peptides were prepared as described previously (39) , and pure MraY translocase was prepared in the laboratory (40) . Antibiotics and reagents were from Sigma.
RESULTS
Overexpression of bacA and Bacitracin Resistance-The wild-type E. coli bacA gene was cloned under control of the strong IPTG-inducible trc promoter in expression vector pTrc99A, yielding plasmid pTrcBac1. The effects of the overexpression of bacA on cell growth and bacitracin resistance were investigated in different E. coli host strains, DH5␣, JM83, or Characterization of E. coli BacA ActivityBW25113, with similar results. Fig. 1 shows the results of experiments performed in DH5␣ background. In liquid medium, no particular effect on growth rate and cell morphology (as judged by optical microscopy) was observed following induction of expression of bacA. In solid medium, however, colonies of clones harboring pTrcBac1 appeared significantly more mucoid than control cell colonies. E. coli and Gram-negative species in general are not very sensitive to bacitracin. As shown in Fig. 1 , lysis of control DH5␣(pTrc99A) cells only occurred at relatively high concentrations of this antibiotic, i.e. 100 -200 g⅐ml Ϫ1 . In the absence of IPTG, cells harboring the pTrcBac1 plasmid appeared slightly less sensitive than control cells to bacitracin. When IPTG (1 mM) was added 5 min before bacitracin, growth of the latter cells remained unaffected even at the highest concentration of antibiotic used (Fig. 1) . This finding clearly established the tight correlation existing between bacA overexpression and bacitracin resistance in E. coli and further indicated that cell resistance to the antibiotic was a process that developed very rapidly.
Overexpression of bacA Results in Increased C 55 -PP Phosphatase Activity-The pTrcBac30 plasmid expressing BacA in the N-terminal His 6 -tagged form was constructed to facilitate purification steps of the protein. The sequence of the cloned bacA gene was verified and shown to be identical to that found in data bases. Taking into account the N-terminal Met-His 6 -Gly-Ser extension, the molecular mass calculated for the E. coli BacA protein was 30,857 Da. E. coli C43(DE3) cells carrying pTrcBac30 (1-liter cultures) were grown and induced or not with IPTG, and crude membrane extracts were prepared. SDS-PAGE analysis of these extracts showed that expression from pTrcBac30 had resulted in a significant overproduction of a protein species migrating between markers of 20 and 30 kDa. That the overproduced protein was BacA was confirmed by Western blot using antibodies targeting the His 6 tag (data not shown). The specific activity of C 55 -OH phosphokinase detected in membranes from induced cells appeared very low and quite similar to that detected in non-induced cells or in control cells carrying the pTrcHis30 vector (ϳ0.006 units/mg of protein). This finding was not consistent with previous data from Cain et al. (18) who reported a 2-4-fold increase of C 55 -OH phosphokinase activity in bacA-overexpressing cells. In fact, as the function of BacA was not clearly established and because bacitracin resistance could also result from an increase of C 55 -PP phosphatase activity, radiolabeled C 55 -PP was synthesized, and an assay was developed to test C 55 -PP phosphatase activity in these extracts. A 280-fold increase of the specific activity of C 55 -PP phosphatase activity was observed in membranes from induced cells as compared with control cells carrying the plasmid vector pTrcHis30 (85 and 0.3 units/mg of protein, respectively). In the absence of IPTG induction, it was already 90-fold higher than in control cells presumably because of a high plasmid copy number and to residual transcription under these conditions. These results, which strongly suggested that BacA exhibited a C 55 -PP phosphatase activity rather than a C 55 -OH phosphokinase activity, prompted us to purify this protein for a more detailed characterization.
Extraction and Purification of the BacA Protein-DDM appeared to be an efficient detergent to extract the BacA protein from membranes of induced cells as judged by SDS-PAGE analysis and Coomassie Blue or Western blot detection of the protein (data not shown). Four successive treatments with DDM were performed, one with 0.9% followed by three with 1% DDM, resulting in extracts DDM1-DDM4, respectively. The levels of C 55 -PP phosphatase activity determined in these different extracts are reported in Table II . The stepwise extraction allowed us to remove significant amounts of proteins but only a little of the BacA protein in DDM1. About one-third of the total activity was recovered in DDM2 with a 65% increase in specific activity. Protein amounts in DDM3 and DDM4 were similar with a specific activity of approximately 125 and 30 units/mg of protein, respectively, as compared with 155 units/mg of protein in DDM2 (Table II) . The DDM2 extract was chosen for subsequent steps of purification of the BacA protein.
The one-step purification of BacA was then carried out by affinity chromatography on Ni 2ϩ -NTA-agarose (see "Experimental Procedures"). Solubilized membranes (DDM2 extract, 70 mg of proteins) were incubated with the resin for 2 h at 4°C with shaking, and washing and elution steps were carried out by using a discontinuous gradient of imidazole (from 10 to 300 mM). Fractions were analyzed by SDS-PAGE, and their protein and C 55 -PP phosphatase contents were determined ( Fig. 2 and Table II ). Almost all of the BacA protein remained bound to the Ni 2ϩ -NTA-agarose up to 20 mM imidazole. It was eluted from the resin at 60 mM imidazole and appeared purified to near homogeneity in fractions containing 100 mM imidazole (Fig. 2) . 
Characterization of E. coli BacA Activity
The molecular mass of the purified protein as deduced from its migration on gels was ϳ27 kDa, a value slightly lower than the calculated value (30,857 Da) as frequently observed with membrane proteins (41) . The levels of C 55 -PP phosphatase activity determined in these fractions (Table II) clearly paralleled the amounts of BacA protein. About 4 mg of BacA protein were obtained from 1 liter of culture, and the most purified fractions showed a C 55 -PP specific activity of 2,200 units/mg of protein, a value about 7,300-fold higher than the basal activity detected in wild-type E. coli cell membranes (ϳ0.3 units/mg of proteins). Assays for C 55 -OH phosphokinase activity of the different fractions showed that this activity was detected only in the crude extract DDM2 and the pass-through fraction (proteins not retained on Ni 2ϩ -NTA-agarose) and that the purified BacA protein did not exhibit at all such an activity (data not shown). These results clearly demonstrated that the BacA protein was a C 55 -PP phosphatase and not a C 55 -OH phosphokinase.
Characterization of the Purified BacA Preparation-MALDI-TOF mass spectrometry analysis of the pure protein in the presence of the detergent necessary to maintain its solubility is always a difficult task. In the present case, spectra were obtained when ␣-cyano-4-hydroxycinnamic acid, a matrix recommended by Cadene and Chait (42) for integral membrane proteins, was used and the samples were prepared according to Grü ber et al. (38) (Fig. 3) . This was roughly in agreement with the molecular mass of the His 6 -tagged protein (30,857 Da), suggesting that the N-terminal methionine has not been eliminated during the in vivo expression of the recombinant protein.
The small excess of mass found (ϳ150 Da) may be attributed to imprecision due to the poor signal. The absence of any other peak up to m/z 100,000 confirmed the purity of the final BacA preparation. Furthermore appropriate enzymatic assays were performed that demonstrated the absence of any traces of MraY transferase, C 55 -PP, and C 55 -P that otherwise could have interfered with the assay (data not shown).
Characterization of the BacA Reaction Product-The C 55 -PP phosphatase assay used in this study was based on the conversion of radiolabeled C 55 -PP to C 55 -P followed by TLC separation on silica gel plates (Fig. 4) . Radioactive spots corresponding to the substrate and product were identified on the basis of their co-migration with authentic commercial standards (R F values of 0.36 and 0.5, respectively) and quantified with a radioactivity scanner. To confirm the nature of the BacA reaction product, a typical reaction was performed using unlabeled C 55 -PP as substrate. After reaction, the mixture was extracted with butanol, and the organic phase was analyzed by MALDI-TOF mass spectrometry. Only a peak of m/z 844.8 was observed (data not shown) that matched the expected value for the [M Ϫ H]
Ϫ ion of C 55 -P (845.6). This result confirmed that the radiolabeled compound formed (Fig. 4) effectively consisted of C 55 -P. We also performed an assay in which the activity of BacA was coupled to that of the MraY transferase, which catalyzes the subsequent step in the pathway for peptidoglycan synthesis. Addition of pure MraY and UDP-MurNAc-pentapeptide resulted in the complete transformation of the C 55 -P produced by BacA into radiolabeled lipid I (new spot with R F value of 0.2, data not shown), further demonstrating the identification of the BacA product as C 55 -P.
Inactivation of the Chromosomal bacA Gene-An E. coli strain with the chromosomal bacA gene disrupted was constructed by using the procedure of Datsenko and Wanner (32) . In this strain, BW25113 ⌬bacA::Cm R , 592 bp of the 819-bp bacA gene sequence were deleted and replaced by a chloramphenicol resistance cartridge. The gene disruption and absence of any copy of the original wild-type gene were confirmed by PCR experiments. This result showed that the bacA gene was not essential for in vitro growth of E. coli. The mutant strain did not exhibit any particular growth defect, morphological change, or modified sensitivity toward bacitracin as compared with the wild-type strain (data not shown). Membranes from both BW25113 and BW25113 ⌬bacA::Cm R strains were prepared, and enzymatic assays showed a 75% decrease of C 55 -PP activity in the mutant strain. This result confirmed the identification of the bacA gene product as a C 55 -PP phosphatase and further revealed its important, but not exclusive contribution, to the total activity detected in a wild-type strain.
DISCUSSION
The C 55 -P carrier lipid is essential for the synthesis of various bacterial cell wall polymers such as peptidoglycan, lipopolysaccharides, and teichoic acids (1) (2) (3) (4) (5) . Its precursor, C 55 -PP, is formed by addition of isoprene units onto farnesyl pyrophosphate, a reaction catalyzed by the cis-prenyl pyrophosphate synthase UppS, the only step of C 55 -P metabolism that has been characterized in detail to date (8 -11) . Genes and enzymes involved in other subsequent steps of C 55 -P synthesis and recycling (Scheme 1) still remain to be identified. The cyclic polypeptide antibiotic bacitracin has been shown to inhibit the synthesis of the aforementioned cell envelope components through sequestration of the carrier lipid precursor C 55 -PP (20, 21) . The targeting of this specific and essential bacterial lipid and the resulting bacteriolytic effect (Fig. 1) have been the basis for the development and therapeutic use of this compound. Bacterial resistance to this antibiotic could be due to a decreased uptake or an efflux system as observed in B. licheniformis producing strain (23) . In E. coli and other Gram-negative bacteria, different mutations have been described that lead to bacitracin resistance, most of them being characterized by a decreased in vivo requirement for the C 55 -P carrier lipid. For instance, defective synthesis of non-essential polymers such as osmoregulated periplasmic glycans or capsular polysaccharides result in antibiotic resistance (25, 26) presumably because inactivation of these C 55 -P-dependent pathways indirectly provides an increased supply of carrier lipid for the synthesis of the essential cell wall component, peptidoglycan. As discussed below, not only mutations but also gene overexpression have reported to be associated with bacitracin resistance (18, 27) .
Cain et al. (18) have previously reported the identification of an E. coli gene, named bacA, the presence of which on multicopy plasmids resulted in an increased resistance to bacitracin. They have shown that membranes from cells harboring bacAcontaining plasmids contained an approximately 4-fold increased level of C 55 -OH phosphokinase activity as compared with control host cell membranes and therefore concluded that C 55 -OH phosphokinase activity should be carried out by the bacA gene product, although this was not undoubtedly established. This question was revisited in the present work. First we cloned the E. coli bacA gene into the efficient expression vector pTrc99A and confirmed the correlation between overexpression of this gene and bacitracin resistance. Then, using appropriate enzymatic assays, we showed that crude membranes from cells overexpressing bacA did not contain an increased level of C 55 -OH phosphokinase activity, contrary to what was observed earlier by Cain et al. (18) , but contained instead a 280-fold increased level of C 55 -PP phosphatase activity. This unexpected result prompted us to purify the BacA protein from membranes to analyze its function in more details. For this purpose the protein was overexpressed in the His 6 -tagged form, extracted from membranes using an appropriate detergent, and purified to near homogeneity as judged by SDS-PAGE and mass spectrometry analyses. This final preparation clearly exhibited a high C 55 -PP phosphatase activity but no detectable C 55 -OH phosphokinase activity. The C 55 -OH phosphokinase activity detected in crude membranes was not retained on the column of Ni 2ϩ -NTA-agarose used for binding and purification of His 6 -BacA protein (data not shown), further demonstrating that this activity was carried by a separate protein species. The increased bacitracin resistance of bacA-overexpressing clones was interpreted previously by Cain et al. (18) as an increased supply of C 55 -P that might result from the overexpression of C 55 -OH phosphokinase activity. This hypothesis was based on the assumption that a significant pool of free C 55 -OH may also exist in E. coli membranes as suggested in some Gram-positive bacteria (13) and that this pool was directed toward the formation of C 55 -P in the presence of an excess of phosphokinase activity (Scheme 1, step 3). In fact, the present identification of BacA as a C 55 -PP phosphatase activity remains perfectly consistent with a bacitracin resistance phenotype. Indeed the high level overexpression of this enzyme should theoretically cause a dramatic depletion of the internal pool of C 55 -PP due to its rapid conversion to C 55 -P. The decreased availability of C 55 -PP, the target of bacitracin, most likely accounts for the increased cell resistance to the antibiotic. Confirmation of this hypothesis requires the devel- opment of efficient techniques allowing the separation and quantification of these different lipids in the bacterial membranes. Competition of bacitracin and BacA protein for the same ligand could also explain the reduced effect of the antibiotic in a BacA-overproducing strain.
The physiological role of BacA is thus to catalyze the dephosphorylation of C 55 -PP, a reaction that generates (or regenerates, see Scheme 1) the essential C 55 -P carrier lipid used for the synthesis of various cell wall components. This is to our knowledge the first gene encoding C 55 -PP phosphatase identified to date. The partial purification and some properties of the C 55 -PP phosphatase from Micrococcus lysodeikticus were reported about 30 years ago by Goldman and Strominger (12) . Four protein bands were still detected by SDS-PAGE in their final preparation that all migrated between 26.0 and 48.5 kDa standards, but the band corresponding to the phosphatase was not identified. This molecular mass range is consistent with the calculated mass of BacA (29, 759 Da for the protein without His 6 tag) and the behavior on polyacrylamide gels of the purified membrane protein purified from E. coli observed in the present study. The size of the C 55 -OH phosphokinase from S. aureus was estimated previously by Sanderman and Strominger to be much lower, about 17 kDa (16, 17) , a finding consistent with the present demonstration that BacA does not exhibit this activity.
The bacA gene has recently been demonstrated to be nonessential for in vitro growth of S. aureus and S. pneumoniae (28) , but disruption of the gene in the latter pathogenic species resulted in a hypersensitivity to bacitracin and a reduced virulence in a mouse model of infection. The latter finding suggested that some metabolic changes had occurred that were sufficient to compromise infectivity. A decreased C 55 -PP phosphatase activity should theoretically cause an accumulation of C 55 -PP (consistent with bacitracin hypersensitivity) and a partial depletion of the pool of the C 55 -P carrier lipid, resulting in the inhibition of synthesis of some of the different cell envelope components. However, Chalker et al. (28) did not observe in these mutant strains differences in morphology or sensitivity to other antibiotics that could be interpreted as a deficiency in cell wall synthesis. In the present work we provided evidence that the bacA gene is also non-essential for viability in E. coli. We showed that its overexpression resulted in bacitracin resistance and mucoidy of solid medium, suggesting an increased production of some exopolysaccharides. Inactivation of the gene, however, did not result in an hypersensitivity to bacitracin presumably because E. coli is naturally less sensitive than Gram-positive bacteria to this antibiotic due to the presence of the additional outer membrane.
The UppS synthase catalyzing the formation of C 55 -PP has been shown to be essential for cell viability in E. coli and S. pneumoniae (8, 10) . The bacteriolytic effect of the sequestration of C 55 -PP by bacitracin confirmed this finding. The same was thus expected for any other enzyme participating in the synthesis of the essential C 55 -P carrier lipid and in particular for the phosphatase catalyzing the subsequent step of dephosphorylation of C 55 -PP. The fact that the chromosomal bacA gene could be disrupted without apparent effect on cell morphology and growth was thus quite surprising. Different hypotheses could be made to explain this finding, such as the occurrence of multiple phosphatase genes or a putative metabolic bypass of the dephosphorylation step. One can effectively speculate that more than one C 55 -PP phosphatase gene exists in E. coli and that in a bacA mutant the other phosphatase(s) could sustain the in vivo requirements of C 55 -P molecules for cell wall polymer synthesis. Such a phosphatase could be specific of C 55 -PP, or it could have a different metabolic function but also display nonspecific activity on C 55 -PP. Multiple genes for diacylglycerol pyrophosphate phosphatase and phosphatidylglycerophosphate phosphatase activities have previously been identified in E. coli (43) (44) (45) , providing an example of such a gene redundancy and functional complementation. In the present study we observed that the C 55 -PP phosphatase activity was reduced by 75% in the disrupted bacA mutant, confirming the contribution of both BacA and another protein species to the detected activity.
It should be noted that C 55 -PP is initially synthesized by UppS at the inner side of the cytoplasmic membrane but that it is also regenerated later at the outer periplasmic side of the membrane in the course of the polymerization steps of cell wall peptidoglycan biosynthesis. This raises the question of the site of dephosphorylation of this compound. Does it take place on each membrane side using different phosphatase activities, or does it occur only on the inner side, implying in that case a flip-flop of the released C 55 -PP prior to dephosphorylation ? As no bacA homologous gene could be detected in the genome of E. coli and other bacteria in which this gene was shown to be non-essential, further work is now required to identify this additional phosphatase and to characterize its substrate specificity.
As already reported by Chalker et al. (28) the gene name bacA has also been used previously to designate bacitracin synthetase of B. licheniformis and a transport protein involved in bacteroid synthesis in Rhizobium species. Considering the newly identified function of the bacA gene product, we propose to rename this gene uppP, for undecaprenyl pyrophosphate phosphatase, to follow the nomenclature previously adopted for enzymes involved in C 55 -P metabolism (uppS for C 55 -PP synthase (8)).
